Sarasota, FL, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug Type (Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, global demand for active pharmaceutical ingredient market was valued at USD 148.22 billion in 2015, is expected to reach USD 213.84 billion in 2021 and is anticipated to grow at a CAGR of 6.3% between 2016 and 2021.
APIs are frequently referred as "bulk pharmaceuticals”. The active pharmaceutical ingredient is a biologically active portion of any pharmaceutical drug. Occasionally, API needs cofactor in order to attain specific effects on the body. Some active pharmaceutical ingredients are unidentified and therefore need additional substances, which can work in combination with the API to generate the required medicinal effect on the body. In herbal medicines, the API is generally a mixture of various substances, which act collectively on the body.
Browse through 68 Tables & 48 Figures spread over 110 Pages and in-depth TOC on "Active Pharmaceutical Ingredients Market by API Synthesis, by Type of Manufacturing, by Type of API, by Drug type and Other Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”.
Request Free Sample copy of Global Active pharmaceutical ingredient Market Size & Trends Analysis Report @ https://www.zionmarketresearch.com/sample/active-pharmaceutical-ingredients-market
The market for API is expected to have the highest growth rate in the forecast period. The increasing prevalence of diabetes, neurological disorders, and other chronic diseases are the major driving factor of the global API market. One of the key drivers of the API market is an increase in the outsourcing of active pharmaceutical ingredients manufactured by pharmaceutical companies which are done to reduce both manufacturing and infrastructure costs. Such outsourced manufacturing activities are carried out by low-cost vendors in the Asia Pacific region.
However, strict regulations are one of the major challenges faced by the global API market. Such regulations are predominantly well defined in developed regions such as North America and Europe. Vendors in this market space are supposed to obey the detailed procedures prior to product commercialization.
Browse the full "Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/active-pharmaceutical-ingredients-market
The global API market is segmented based on API synthesis, type of manufacturing, and type of API, application and by region. Depending on synthesis market is classified into biotech API, synthetic chemical API, and HPAPI. On the basis of the type of drug, the market is segmented into branded drugs, generic drugs, and OTC (Over the Counter) drugs. The branded drug segment accounted for the largest share in 2015. Different therapeutic application of the API market includes cardiology, oncology, anti-inflammatory, gastrointestinal and others. The oncology segment is anticipated to grow at the highest growth rate in coming years due to increasing prevalence of cancer worldwide.
North America dominated the API market and accounted for more than 35% share of the global API market in 2015. Government approvals for the production of novel medications and increasing awareness about the intake of generic drugs have led to the growth of the API market in North America.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/active-pharmaceutical-ingredients-market
Europe was one of the leading players in global API market. European active pharmaceutical ingredients (API) market held a share of around 24% of the global market. Germany and France were the largest revenue contributors in this region. European government policy strongly supports the consumption of generic drugs over the branded drug, which is expected to increase the revenue of the generic drugs over the branded drugs in this region. API market in Europe is predicted to grow at a moderate rate in the near future.
Asia Pacific region is expected to be the fastest developing API market owing to low working costs, contract manufacturing organizations services and high investments in biological research. In addition, the high cost of skilled labor and energy are the main issues that forced European vendors to transfer their base to countries such as India and China. The pharmaceutical drug industry of Asia Pacific is growing by leaps at present. India is now one of the leading exporters of API and supplies them to around 200 countries worldwide.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/56
Latin America represents huge potential for API market due to rapidly expanding economies and improving healthcare sector. In 2015, Mexico was the largest market in Latin America. Brazil is expected to show noteworthy growth due to increasing aging population and strengthening healthcare systems.
Middle East & Africa is expected to witness decent growth in coming years due to increasing prevalence of various infections and developing pharmaceutical industry in the region.
(Purchase Single User License of this report at Flat USD 2939)
Directly Purchase a copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/active-pharmaceutical-ingredients-market
Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others are some of the leading players in API market.
For media inquiry contact our sales team @ sales@zionmarketresearch.com
The report segments the global active pharmaceutical ingredient market as:
Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis
- Biotech API
- Synthetic Chemical API
- HPAPI
Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis
- Contract Manufacturing
- In-House API Manufacturing
Active Pharmaceutical Ingredient Market: Type of API Segment Analysis
- Synthetic API
- Biological API
Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis
- Branded Drugs
- Generic Drugs
- OTC Drugs
Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis
- Cardiology
- Oncology
- Anti-Inflammatory
- Gastrointestinal
- Other
Related Reports:
- Antithrombin Market: https://www.zionmarketresearch.com/report/antithrombin-market
- Alzheimer’s Drugs Market: https://www.zionmarketresearch.com/report/alzheimers-drugs-market
- Acromegaly Treatment Market: https://www.zionmarketresearch.com/report/acromegaly-treatment-market
- Hepatitis C Drug Market: https://www.zionmarketresearch.com/report/hepatitis-c-drug-market
- Melanoma Drugs Market: https://www.zionmarketresearch.com/report/melanoma-drugs-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research